2m 2m 2m 2m 2m 2m 2m
VAXCYTE (PCVX)
NASDAQ
$68.14-$0.48 (-0.70%)
Price as of Nov 12, 2026 8:11 AM EST- $10.9BMarket Cap
- 48.85%1-Year Change
- BiotechnologyIndustry
VAXCYTE (PCVX)
$68.14-$0.48 (-0.70%)
PCVX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $68.62 | ||
Change | +$2.26 (+3.41%) | ||
Open | $67.19 | ||
High | $68.92 | ||
Low | $66.56 | ||
Previous Close | $66.36 | ||
Volume | 1,640,961 | ||
30-Day Average Volume | 2,122,465 | ||
1-Week Change | 4.48% | ||
1-Month Change | -3.87% | ||
1-Year Change | 48.85% | ||
3-Year Change | 42.54% | ||
5-Year Change | 166.38% | ||
Fundamentals | |||
Shares Outstanding | 158.3M | ||
Total Assets | $3.0B | ||
Market Cap | $10.9B | ||
Enterprise Value | $10.7B | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$297.1M | ||
Free Cash Flow | -$227.4M | ||
EBIT | -$297.1M | ||
EBITDA | -$291.3M | ||
Net Working Capital | $1.1B | ||
EPS | -$1.99 | ||
Enterprise Value/EBITDA | -37 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 4 | ||
P/E | -34 | ||
PEG | 34 | ||
Price/Free Cash Flow | -48 | ||
Price/Operating Cash Flow | -48 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue